The Price Gap: Verified
Brand-name Zepbound (FDA-approved tirzepatide)
| Path | Verified cash price | Notes | Verified |
|---|---|---|---|
| Ro, Zepbound KwikPen | From $299 first month, then $399–$449/mo, billed separately from Ro’s $149/mo membership ($74/mo on annual prepay) | All-in cash total ≈ $473–$598/mo ($399–$449 KwikPen + $74–$149 membership); Ro helps run insurance prior authorization, which can change the math entirely | Jul 3, 2026 |
Compounded tirzepatide (not FDA-approved)
| Program | Verified entry price | Notes | Verified |
|---|---|---|---|
| Trimi | $125/mo (annual plan), the lowest compounded tirzepatide figure we track | Annual plan billed yearly up front | 2026-08-21 |
| TMates | $167/mo (12-month plan) | Visits + medication included; injectable and oral options | Jul 9, 2026 |
| Sprout Health | From $199/mo (starting dose) | Higher doses cost more | Jul 3, 2026 |
| Mochi Health | $199/mo (all doses) + $79/mo membership | ~$278/mo combined | Jul 3, 2026 |
| Direct Meds | From $299/mo (sublingual) to $399/mo (injection) | All-inclusive; not available in LA | 2026-07-25 |
| ShedRx | Injections from $299/mo | Semaglutide tiers cost less | 2026-09-03 |
What You’re Actually Paying For
The price gap is a regulatory-status gap. Zepbound is Eli Lilly’s FDA-approved tirzepatide: manufactured under full FDA oversight, dosed in fixed pens, supported by the clinical-trial evidence on its label. Compounded tirzepatide is prepared by state-licensed 503A pharmacies or 503B outsourcing facilities for an individual patient, and not reviewed by the FDA for safety, effectiveness, or quality, and clinical-trial results from the approved product shouldn’t be assumed to transfer.
Two more things change the math. First, insurance: if your plan covers Zepbound, your copay can undercut every compounded price on this page, Ro’s membership includes prior-authorization help for exactly that reason. Second, regulatory risk on the compounded side: the FDA has proposed excluding semaglutide and tirzepatide from the 503B bulk compounding list (the public comment period, extended to July 30, 2026, has now closed). If finalized, availability and pricing of compounded programs could change, a reason to avoid long prepaid commitments.
How to Choose
- Insurance might cover Zepbound: pursue that first, it beats every cash path. Ro’s membership is built around this.
- Paying cash, want the lowest tirzepatide price: the lowest verified compounded tirzepatide figure we track is $119/mo (Embody), out of 19 programs publishing one, see the full tirzepatide ranking. TMates is $167/mo (12-month plan).
- Paying cash, want FDA-approved certainty: budget $473–$598/mo through Ro, or compare semaglutide instead, see the GLP-1 Price Index.
- Undecided on compounded vs brand: our full breakdown covers the safety and evidence tradeoffs.
Safety note: Compounded medications are not FDA-approved finished drug products and are not reviewed by the FDA for safety, effectiveness, or quality before sale. Zepbound is a registered trademark of Eli Lilly and Company; RangeYourself is not affiliated with Eli Lilly. No GLP-1 medication should be used without a prescription from a licensed clinician. GLP-1 medications are not appropriate for everyone, including, per FDA labeling for tirzepatide, people with a personal or family history of medullary thyroid carcinoma or MEN2, and side effects can include nausea, vomiting, diarrhea, constipation, abdominal pain, and dehydration.
FAQ
How much cheaper is compounded tirzepatide than Zepbound?
The lowest verified compounded tirzepatide price we track is $119/mo (Embody), across 19 programs that publish one; most entry prices sit higher and injection formats higher still. Brand-name Zepbound through Ro totals roughly $473–$598/month with membership. Insurance coverage for Zepbound flips this entirely.
Is compounded tirzepatide the same drug as Zepbound?
Different regulatory status, and the FDA does not treat every compounded preparation as carrying the identical active ingredient. Zepbound is the FDA-approved product; compounded tirzepatide is pharmacy-prepared and not FDA-reviewed for safety, effectiveness, or quality. Compounders describe their preparations as using the same active ingredient; the FDA has warned that some compounded GLP-1 products use salt forms it considers different active ingredients from the approved drug. That difference is what the price gap buys.
Will compounded tirzepatide stay available?
Uncertain. The FDA has proposed excluding tirzepatide from the 503B bulk compounding list (the comment period, extended to July 30, 2026, has now closed). If finalized, compounded availability and pricing could change. We’ll update this page as the situation develops.
Can any program guarantee a prescription?
No. Licensed clinicians prescribe only when treatment is clinically appropriate. A guaranteed prescription is a red flag anywhere.
RangeYourself may earn a commission if you sign up through links on this page, see how we make money. Rankings are based on verified pricing, never on commissions. Prices change frequently, always confirm current rates on each provider’s website before purchasing.
Reliability notes
Independently observed Trustpilot and BBB data for the programs above, reported as found, including any that are middling, small-sample, unaccredited, or flagged. This is a third-party signal, not our own editorial ranking, and it is not a substitute for reading a program’s full review.
Full per-provider detail, methodology, and our read on what these signals do and don’t mean: GLP-1 Provider Reliability Report.
RangeYourself is reader-supported. We may earn a commission when you click on certain links, at no extra cost to you. Editorial recommendations are made independently. Content last updated August 21, 2026.
